These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25174930)

  • 1. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
    Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
    Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in antiretroviral drug delivery using nanotechnology.
    Mallipeddi R; Rohan LC
    Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting slow effective release antiretroviral therapy.
    Edagwa B; McMillan J; Sillman B; Gendelman HE
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1281-1291. PubMed ID: 28128004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and the treatment of HIV infection.
    Parboosing R; Maguire GE; Govender P; Kruger HG
    Viruses; 2012 Apr; 4(4):488-520. PubMed ID: 22590683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.
    Guo D; Li T; McMillan J; Sajja BR; Puligujja P; Boska MD; Gendelman HE; Liu XM
    Nanomedicine (Lond); 2014 Jul; 9(9):1341-52. PubMed ID: 23905578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicines for HIV therapy.
    Siccardi M; Martin P; McDonald TO; Liptrott NJ; Giardiello M; Rannard S; Owen A
    Ther Deliv; 2013 Feb; 4(2):153-6. PubMed ID: 23343155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
    Wong HL; Chattopadhyay N; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery.
    Takalani F; Kumar P; Kondiah PPD; Choonara YE; Pillay V
    Pharm Dev Technol; 2020 Mar; 25(3):267-280. PubMed ID: 31744408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
    Date AA; Destache CJ
    Biomaterials; 2013 Aug; 34(26):6202-28. PubMed ID: 23726227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards nanomedicines for neuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
    Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
    Gunaseelan S; Gunaseelan K; Deshmukh M; Zhang X; Sinko PJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):518-31. PubMed ID: 19941919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.
    Dash PK; Gendelman HE; Roy U; Balkundi S; Alnouti Y; Mosley RL; Gelbard HA; McMillan J; Gorantla S; Poluektova LY
    AIDS; 2012 Nov; 26(17):2135-44. PubMed ID: 22824628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles and Its Implications in HIV/AIDS Therapy.
    Oti VB
    Curr Drug Discov Technol; 2020; 17(4):448-456. PubMed ID: 31250759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs.
    Herskovitz J; Hasan M; Machhi J; Mukadam I; Ottemann BM; Hilaire JR; Woldstad C; McMillan J; Liu Y; Seravalli J; Sarella A; Gendelman HE; Kevadiya BD
    Nanotheranostics; 2021; 5(4):417-430. PubMed ID: 33972918
    [No Abstract]   [Full Text] [Related]  

  • 20. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
    Wu KY; Wang XC; Anderson M; Tran SD
    Molecules; 2024 May; 29(10):. PubMed ID: 38792122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.